to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Dr. Bomprezzi is fellowship trained in neuroimmunology and he is involved in the treatment of inflammatory disorders of the central nervous system, such as multiple sclerosis, neuromyelitis optica, neurosarcoidosis.
One or more keywords matched the following items that are connected to
Multiple Sclerosis, Relapsing-Remitting
Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families.
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis.
An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population.
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population.
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study.
Gene expression profiles reveal homeostatic dynamics during interferon-beta therapy in multiple sclerosis.
Head tremor secondary to MS resolved with rituximab.
Glatiramer acetate-specific antibody titres in patients with relapsing?/?remitting multiple sclerosis and in experimental autoimmune encephalomyelitis.
IFN?-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Extended interval dosing of natalizumab in multiple sclerosis.
Cervical spondylosis is a risk factor for localized spinal cord lesions in multiple sclerosis.